Zentalis Pharmaceuticals, Inc. (ZNTL)
3.80
-0.08
(-2.06%)
USD |
NASDAQ |
Aug 28, 16:00
3.80
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Price to Book Value : 1.896 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.896 |
| August 27, 2026 | 1.936 |
| August 26, 2026 | 1.941 |
| August 25, 2026 | 1.936 |
| August 24, 2026 | 1.876 |
| August 21, 2026 | 1.908 |
| August 20, 2026 | 1.916 |
| August 19, 2026 | 1.906 |
| August 18, 2026 | 1.836 |
| August 17, 2026 | 1.848 |
| August 14, 2026 | 1.776 |
| August 13, 2026 | 2.070 |
| August 12, 2026 | 2.140 |
| August 11, 2026 | 2.051 |
| August 10, 2026 | 2.070 |
| August 07, 2026 | 2.106 |
| August 06, 2026 | 2.495 |
| August 05, 2026 | 2.470 |
| August 04, 2026 | 2.435 |
| August 03, 2026 | 2.32 |
| July 31, 2026 | 2.365 |
| July 30, 2026 | 2.455 |
| July 29, 2026 | 2.33 |
| July 28, 2026 | 2.305 |
| July 27, 2026 | 2.250 |
| Date | Value |
|---|---|
| July 24, 2026 | 2.160 |
| July 23, 2026 | 2.220 |
| July 22, 2026 | 2.245 |
| July 21, 2026 | 2.500 |
| July 20, 2026 | 2.500 |
| July 17, 2026 | 2.550 |
| July 16, 2026 | 2.280 |
| July 15, 2026 | 2.385 |
| July 14, 2026 | 2.380 |
| July 13, 2026 | 2.305 |
| July 10, 2026 | 2.435 |
| July 09, 2026 | 2.345 |
| July 08, 2026 | 2.425 |
| July 07, 2026 | 2.385 |
| July 06, 2026 | 2.355 |
| July 02, 2026 | 2.225 |
| July 01, 2026 | 2.173 |
| June 30, 2026 | 2.420 |
| June 29, 2026 | 1.796 |
| June 26, 2026 | 1.574 |
| June 25, 2026 | 1.476 |
| June 24, 2026 | 1.546 |
| June 23, 2026 | 1.433 |
| June 22, 2026 | 1.430 |
| June 18, 2026 | 1.441 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ARS Pharmaceuticals, Inc. | 46.81 |
| ACADIA Pharmaceuticals, Inc. | 3.835 |
| Alnylam Pharmaceuticals, Inc. | 23.42 |
| Anika Therapeutics, Inc. | 2.057 |
| Savara, Inc. | 7.520 |
Price to Book Value Related Metrics
| Price | 3.80 |
| Earnings Yield | -51.51% |
| Market Cap | 272.34M |